αααααβααΎαORXOF β’ OTCMKTS
add
Orexo AB
2.24$
27 ααααΆ, 12:20:01 AM ααααβααα -4 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·α
αα·αααΈαα»α
2.24$
α
ααααααα½αααααΆαα
α»αααααα
1.90$ - 3.23$
ααΎαβαα»αβααΈααααΆα
76.66Β ααΆα USD
ααα ααα½αααΌαααααα
44.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
STO
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (SEK) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 3.30Β ααΆα | -97.94% |
α
αααΆαααααα·ααααα·ααΆα | 80.70Β ααΆα | β |
α
αααΌααα»ααα | 724.80Β ααΆα | β |
ααααΆααα
αααααα»ααα | 21.96Β ααΆαα | β |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -46.80Β ααΆα | β |
α’ααααΆαααααααααΆαααααα·αααααΆα | -0.09% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (SEK) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 912.40Β ααΆα | 639.98% |
ααααααααα»α | 1.30Β αααΈααΆα | 119.03% |
ααΆαααα½ααα»αααααΌαααα»α | 812.20Β ααΆα | 12.63% |
ααΌαβααααα»α | 490.60Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 34.71Β ααΆα | β |
ααααααααααΉαααααα
| 0.16 | β |
ααα
ααααααΎαααααα | -21.96% | β |
ααα
ααααααΎααΎααα»α | -32.02% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (SEK) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 724.80Β ααΆα | β |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 806.20Β ααΆα | β |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | β | β |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 4.80Β ααΆα | β |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 806.70Β ααΆα | β |
ααα αΌαααΆα
αααααΆααααααα | 40.78Β ααΆα | β |
α’αααΈ
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
ααΆααααααΎαα‘αΎα
1995
αααααβαααααΆα
αα»ααααα·α
74